API: Exclusive supply still a ‘very big issue’

The CEO of one of Australia’s leading pharmaceutical distributors says he wishes a solution had been organised “yesterday” Exclusive supply of medicines is still a “very big issue”, says Richard Vincent, CEO and Managing Director of Australian Pharmaceutical Industries (API) and Deputy Chairman of the National Pharmaceutical Services Association (NPSA), which represents Australian pharmaceutical wholesalers.